What is LOPJLB’s current signal on CRIS?

LOPJLB’s latest quantitative signal on Curis, Inc. (CRIS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CRIS in?

Curis, Inc. (CRIS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Curis, Inc. (CRIS) do?

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysp…